• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market by Geography
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Drug Class
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Disease Type
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2023
o 3.4 Market outlook: Forecast for 2023-2028
o Exhibit 14: Chart on Global – Market size and forecast 2023-2028 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2023-2028 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• 4 Historic Market Size
o 4.1 Global gastroparesis drugs market 2018 – 2022
o Exhibit 18: Historic Market Size – Data Table on global gastroparesis drugs market 2018 – 2022 ($ million)
o 4.2 Drug Class Segment Analysis 2018 – 2022
o Exhibit 19: Historic Market Size – Drug Class Segment 2018 – 2022 ($ million)
o 4.3 Disease Type Segment Analysis 2018 – 2022
o Exhibit 20: Historic Market Size – Disease Type Segment 2018 – 2022 ($ million)
o 4.4 Geography Segment Analysis 2018 – 2022
o Exhibit 21: Historic Market Size – Geography Segment 2018 – 2022 ($ million)
o 4.5 Country Segment Analysis 2018 – 2022
o Exhibit 22: Historic Market Size – Country Segment 2018 – 2022 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2023 and 2028
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2023 and 2028
• 6 Market Segmentation by Drug Class
o 6.1 Market segments
o Exhibit 30: Chart on Drug Class – Market share 2023-2028 (%)
o Exhibit 31: Data Table on Drug Class – Market share 2023-2028 (%)
o 6.2 Comparison by Drug Class
o Exhibit 32: Chart on Comparison by Drug Class
o Exhibit 33: Data Table on Comparison by Drug Class
o 6.3 Prokinetic agents – Market size and forecast 2023-2028
o Exhibit 34: Chart on Prokinetic agents – Market size and forecast 2023-2028 ($ million)
o Exhibit 35: Data Table on Prokinetic agents – Market size and forecast 2023-2028 ($ million)
o Exhibit 36: Chart on Prokinetic agents – Year-over-year growth 2023-2028 (%)
o Exhibit 37: Data Table on Prokinetic agents – Year-over-year growth 2023-2028 (%)
o 6.4 Antiemetics – Market size and forecast 2023-2028
o Exhibit 38: Chart on Antiemetics – Market size and forecast 2023-2028 ($ million)
o Exhibit 39: Data Table on Antiemetics – Market size and forecast 2023-2028 ($ million)
o Exhibit 40: Chart on Antiemetics – Year-over-year growth 2023-2028 (%)
o Exhibit 41: Data Table on Antiemetics – Year-over-year growth 2023-2028 (%)
o 6.5 Botulinum toxin injection – Market size and forecast 2023-2028
o Exhibit 42: Chart on Botulinum toxin injection – Market size and forecast 2023-2028 ($ million)
o Exhibit 43: Data Table on Botulinum toxin injection – Market size and forecast 2023-2028 ($ million)
o Exhibit 44: Chart on Botulinum toxin injection – Year-over-year growth 2023-2028 (%)
o Exhibit 45: Data Table on Botulinum toxin injection – Year-over-year growth 2023-2028 (%)
o 6.6 Market opportunity by Drug Class
o Exhibit 46: Market opportunity by Drug Class ($ million)
o Exhibit 47: Data Table on Market opportunity by Drug Class ($ million)
• 7 Market Segmentation by Disease Type
o 7.1 Market segments
o Exhibit 48: Chart on Disease Type – Market share 2023-2028 (%)
o Exhibit 49: Data Table on Disease Type – Market share 2023-2028 (%)
o 7.2 Comparison by Disease Type
o Exhibit 50: Chart on Comparison by Disease Type
o Exhibit 51: Data Table on Comparison by Disease Type
o 7.3 Idiopathic gastroparesis – Market size and forecast 2023-2028
o Exhibit 52: Chart on Idiopathic gastroparesis – Market size and forecast 2023-2028 ($ million)
o Exhibit 53: Data Table on Idiopathic gastroparesis – Market size and forecast 2023-2028 ($ million)
o Exhibit 54: Chart on Idiopathic gastroparesis – Year-over-year growth 2023-2028 (%)
o Exhibit 55: Data Table on Idiopathic gastroparesis – Year-over-year growth 2023-2028 (%)
o 7.4 Diabetic gastroparesis – Market size and forecast 2023-2028
o Exhibit 56: Chart on Diabetic gastroparesis – Market size and forecast 2023-2028 ($ million)
o Exhibit 57: Data Table on Diabetic gastroparesis – Market size and forecast 2023-2028 ($ million)
o Exhibit 58: Chart on Diabetic gastroparesis – Year-over-year growth 2023-2028 (%)
o Exhibit 59: Data Table on Diabetic gastroparesis – Year-over-year growth 2023-2028 (%)
o 7.5 Post-surgical gastroparesis – Market size and forecast 2023-2028
o Exhibit 60: Chart on Post-surgical gastroparesis – Market size and forecast 2023-2028 ($ million)
o Exhibit 61: Data Table on Post-surgical gastroparesis – Market size and forecast 2023-2028 ($ million)
o Exhibit 62: Chart on Post-surgical gastroparesis – Year-over-year growth 2023-2028 (%)
o Exhibit 63: Data Table on Post-surgical gastroparesis – Year-over-year growth 2023-2028 (%)
o 7.6 Market opportunity by Disease Type
o Exhibit 64: Market opportunity by Disease Type ($ million)
o Exhibit 65: Data Table on Market opportunity by Disease Type ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 67: Chart on Market share by geography 2023-2028 (%)
o Exhibit 68: Data Table on Market share by geography 2023-2028 (%)
o 9.2 Geographic comparison
o Exhibit 69: Chart on Geographic comparison
o Exhibit 70: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2023-2028
o Exhibit 71: Chart on North America – Market size and forecast 2023-2028 ($ million)
o Exhibit 72: Data Table on North America – Market size and forecast 2023-2028 ($ million)
o Exhibit 73: Chart on North America – Year-over-year growth 2023-2028 (%)
o Exhibit 74: Data Table on North America – Year-over-year growth 2023-2028 (%)
o 9.4 Europe – Market size and forecast 2023-2028
o Exhibit 75: Chart on Europe – Market size and forecast 2023-2028 ($ million)
o Exhibit 76: Data Table on Europe – Market size and forecast 2023-2028 ($ million)
o Exhibit 77: Chart on Europe – Year-over-year growth 2023-2028 (%)
o Exhibit 78: Data Table on Europe – Year-over-year growth 2023-2028 (%)
o 9.5 Asia – Market size and forecast 2023-2028
o Exhibit 79: Chart on Asia – Market size and forecast 2023-2028 ($ million)
o Exhibit 80: Data Table on Asia – Market size and forecast 2023-2028 ($ million)
o Exhibit 81: Chart on Asia – Year-over-year growth 2023-2028 (%)
o Exhibit 82: Data Table on Asia – Year-over-year growth 2023-2028 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2023-2028
o Exhibit 83: Chart on Rest of World (ROW) – Market size and forecast 2023-2028 ($ million)
o Exhibit 84: Data Table on Rest of World (ROW) – Market size and forecast 2023-2028 ($ million)
o Exhibit 85: Chart on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
o Exhibit 86: Data Table on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
o 9.7 US – Market size and forecast 2023-2028
o Exhibit 87: Chart on US – Market size and forecast 2023-2028 ($ million)
o Exhibit 88: Data Table on US – Market size and forecast 2023-2028 ($ million)
o Exhibit 89: Chart on US – Year-over-year growth 2023-2028 (%)
o Exhibit 90: Data Table on US – Year-over-year growth 2023-2028 (%)
o 9.8 China – Market size and forecast 2023-2028
o Exhibit 91: Chart on China – Market size and forecast 2023-2028 ($ million)
o Exhibit 92: Data Table on China – Market size and forecast 2023-2028 ($ million)
o Exhibit 93: Chart on China – Year-over-year growth 2023-2028 (%)
o Exhibit 94: Data Table on China – Year-over-year growth 2023-2028 (%)
o 9.9 Germany – Market size and forecast 2023-2028
o Exhibit 95: Chart on Germany – Market size and forecast 2023-2028 ($ million)
o Exhibit 96: Data Table on Germany – Market size and forecast 2023-2028 ($ million)
o Exhibit 97: Chart on Germany – Year-over-year growth 2023-2028 (%)
o Exhibit 98: Data Table on Germany – Year-over-year growth 2023-2028 (%)
o 9.10 UK – Market size and forecast 2023-2028
o Exhibit 99: Chart on UK – Market size and forecast 2023-2028 ($ million)
o Exhibit 100: Data Table on UK – Market size and forecast 2023-2028 ($ million)
o Exhibit 101: Chart on UK – Year-over-year growth 2023-2028 (%)
o Exhibit 102: Data Table on UK – Year-over-year growth 2023-2028 (%)
o 9.11 Japan – Market size and forecast 2023-2028
o Exhibit 103: Chart on Japan – Market size and forecast 2023-2028 ($ million)
o Exhibit 104: Data Table on Japan – Market size and forecast 2023-2028 ($ million)
o Exhibit 105: Chart on Japan – Year-over-year growth 2023-2028 (%)
o Exhibit 106: Data Table on Japan – Year-over-year growth 2023-2028 (%)
o 9.12 Market opportunity by geography
o Exhibit 107: Market opportunity by geography ($ million)
o Exhibit 108: Data Tables on Market opportunity by geography ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 109: Impact of drivers and challenges in 2023 and 2028
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 111: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 112: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 113: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 114: Matrix on vendor position and classification
o 12.3 Abbott Laboratories
o Exhibit 115: Abbott Laboratories – Overview
o Exhibit 116: Abbott Laboratories – Business segments
o Exhibit 117: Abbott Laboratories – Key news
o Exhibit 118: Abbott Laboratories – Key offerings
o Exhibit 119: Abbott Laboratories – Segment focus
o 12.4 AbbVie Inc.
o Exhibit 120: AbbVie Inc. – Overview
o Exhibit 121: AbbVie Inc. – Product / Service
o Exhibit 122: AbbVie Inc. – Key news
o Exhibit 123: AbbVie Inc. – Key offerings
o 12.5 ANI Pharmaceuticals Inc.
o Exhibit 124: ANI Pharmaceuticals Inc. – Overview
o Exhibit 125: ANI Pharmaceuticals Inc. – Product / Service
o Exhibit 126: ANI Pharmaceuticals Inc. – Key offerings
o 12.6 Bausch Health Companies Inc.
o Exhibit 127: Bausch Health Companies Inc. – Overview
o Exhibit 128: Bausch Health Companies Inc. – Business segments
o Exhibit 129: Bausch Health Companies Inc. – Key news
o Exhibit 130: Bausch Health Companies Inc. – Key offerings
o Exhibit 131: Bausch Health Companies Inc. – Segment focus
o 12.7 Cadila Pharmaceuticals Ltd.
o Exhibit 132: Cadila Pharmaceuticals Ltd. – Overview
o Exhibit 133: Cadila Pharmaceuticals Ltd. – Product / Service
o Exhibit 134: Cadila Pharmaceuticals Ltd. – Key offerings
o 12.8 Eisai Co. Ltd.
o Exhibit 135: Eisai Co. Ltd. – Overview
o Exhibit 136: Eisai Co. Ltd. – Business segments
o Exhibit 137: Eisai Co. Ltd. – Key offerings
o Exhibit 138: Eisai Co. Ltd. – Segment focus
o 12.9 Evoke Pharma Inc.
o Exhibit 139: Evoke Pharma Inc. – Overview
o Exhibit 140: Evoke Pharma Inc. – Product / Service
o Exhibit 141: Evoke Pharma Inc. – Key offerings
o 12.10 GlaxoSmithKline Plc
o Exhibit 142: GlaxoSmithKline Plc – Overview
o Exhibit 143: GlaxoSmithKline Plc – Business segments
o Exhibit 144: GlaxoSmithKline Plc – Key news
o Exhibit 145: GlaxoSmithKline Plc – Key offerings
o Exhibit 146: GlaxoSmithKline Plc – Segment focus
o 12.11 Ipca Laboratories Ltd.
o Exhibit 147: Ipca Laboratories Ltd. – Overview
o Exhibit 148: Ipca Laboratories Ltd. – Product / Service
o Exhibit 149: Ipca Laboratories Ltd. – Key offerings
o 12.12 Medtronic Plc
o Exhibit 150: Medtronic Plc – Overview
o Exhibit 151: Medtronic Plc – Business segments
o Exhibit 152: Medtronic Plc – Key news
o Exhibit 153: Medtronic Plc – Key offerings
o Exhibit 154: Medtronic Plc – Segment focus
o 12.13 Otsuka Pharmaceutical Co. Ltd.
o Exhibit 155: Otsuka Pharmaceutical Co. Ltd. – Overview
o Exhibit 156: Otsuka Pharmaceutical Co. Ltd. – Product / Service
o Exhibit 157: Otsuka Pharmaceutical Co. Ltd. – Key offerings
o 12.14 Pfizer Inc.
o Exhibit 158: Pfizer Inc. – Overview
o Exhibit 159: Pfizer Inc. – Product / Service
o Exhibit 160: Pfizer Inc. – Key news
o Exhibit 161: Pfizer Inc. – Key offerings
o 12.15 Processa Pharmaceuticals Inc.
o Exhibit 162: Processa Pharmaceuticals Inc. – Overview
o Exhibit 163: Processa Pharmaceuticals Inc. – Product / Service
o Exhibit 164: Processa Pharmaceuticals Inc. – Key offerings
o 12.16 Takeda Pharmaceutical Co. Ltd.
o Exhibit 165: Takeda Pharmaceutical Co. Ltd. – Overview
o Exhibit 166: Takeda Pharmaceutical Co. Ltd. – Product / Service
o Exhibit 167: Takeda Pharmaceutical Co. Ltd. – Key news
o Exhibit 168: Takeda Pharmaceutical Co. Ltd. – Key offerings
o 12.17 Vanda Pharmaceuticals Inc.
o Exhibit 169: Vanda Pharmaceuticals Inc. – Overview
o Exhibit 170: Vanda Pharmaceuticals Inc. – Product / Service
o Exhibit 171: Vanda Pharmaceuticals Inc. – Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 172: Inclusions checklist
o Exhibit 173: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 174: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 175: Research methodology
o Exhibit 176: Validation techniques employed for market sizing
o Exhibit 177: Information sources
o 13.5 List of abbreviations
o Exhibit 178: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market by Geography
Exhibits5: Executive Summary – Chart on Market Segmentation by Drug Class
Exhibits6: Executive Summary – Chart on Market Segmentation by Disease Type
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2023-2028 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2023-2028 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size – Data Table on global gastroparesis drugs market 2018 – 2022 ($ million)
Exhibits19: Historic Market Size – Drug Class Segment 2018 – 2022 ($ million)
Exhibits20: Historic Market Size – Disease Type Segment 2018 – 2022 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2018 – 2022 ($ million)
Exhibits22: Historic Market Size – Country Segment 2018 – 2022 ($ million)
Exhibits23: Five forces analysis – Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants – Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes – Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry – Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition – Five forces 2023 and 2028
Exhibits30: Chart on Drug Class – Market share 2023-2028 (%)
Exhibits31: Data Table on Drug Class – Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Drug Class
Exhibits33: Data Table on Comparison by Drug Class
Exhibits34: Chart on Prokinetic agents – Market size and forecast 2023-2028 ($ million)
Exhibits35: Data Table on Prokinetic agents – Market size and forecast 2023-2028 ($ million)
Exhibits36: Chart on Prokinetic agents – Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Prokinetic agents – Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Antiemetics – Market size and forecast 2023-2028 ($ million)
Exhibits39: Data Table on Antiemetics – Market size and forecast 2023-2028 ($ million)
Exhibits40: Chart on Antiemetics – Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Antiemetics – Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on Botulinum toxin injection – Market size and forecast 2023-2028 ($ million)
Exhibits43: Data Table on Botulinum toxin injection – Market size and forecast 2023-2028 ($ million)
Exhibits44: Chart on Botulinum toxin injection – Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on Botulinum toxin injection – Year-over-year growth 2023-2028 (%)
Exhibits46: Market opportunity by Drug Class ($ million)
Exhibits47: Data Table on Market opportunity by Drug Class ($ million)
Exhibits48: Chart on Disease Type – Market share 2023-2028 (%)
Exhibits49: Data Table on Disease Type – Market share 2023-2028 (%)
Exhibits50: Chart on Comparison by Disease Type
Exhibits51: Data Table on Comparison by Disease Type
Exhibits52: Chart on Idiopathic gastroparesis – Market size and forecast 2023-2028 ($ million)
Exhibits53: Data Table on Idiopathic gastroparesis – Market size and forecast 2023-2028 ($ million)
Exhibits54: Chart on Idiopathic gastroparesis – Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on Idiopathic gastroparesis – Year-over-year growth 2023-2028 (%)
Exhibits56: Chart on Diabetic gastroparesis – Market size and forecast 2023-2028 ($ million)
Exhibits57: Data Table on Diabetic gastroparesis – Market size and forecast 2023-2028 ($ million)
Exhibits58: Chart on Diabetic gastroparesis – Year-over-year growth 2023-2028 (%)
Exhibits59: Data Table on Diabetic gastroparesis – Year-over-year growth 2023-2028 (%)
Exhibits60: Chart on Post-surgical gastroparesis – Market size and forecast 2023-2028 ($ million)
Exhibits61: Data Table on Post-surgical gastroparesis – Market size and forecast 2023-2028 ($ million)
Exhibits62: Chart on Post-surgical gastroparesis – Year-over-year growth 2023-2028 (%)
Exhibits63: Data Table on Post-surgical gastroparesis – Year-over-year growth 2023-2028 (%)
Exhibits64: Market opportunity by Disease Type ($ million)
Exhibits65: Data Table on Market opportunity by Disease Type ($ million)
Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits67: Chart on Market share by geography 2023-2028 (%)
Exhibits68: Data Table on Market share by geography 2023-2028 (%)
Exhibits69: Chart on Geographic comparison
Exhibits70: Data Table on Geographic comparison
Exhibits71: Chart on North America – Market size and forecast 2023-2028 ($ million)
Exhibits72: Data Table on North America – Market size and forecast 2023-2028 ($ million)
Exhibits73: Chart on North America – Year-over-year growth 2023-2028 (%)
Exhibits74: Data Table on North America – Year-over-year growth 2023-2028 (%)
Exhibits75: Chart on Europe – Market size and forecast 2023-2028 ($ million)
Exhibits76: Data Table on Europe – Market size and forecast 2023-2028 ($ million)
Exhibits77: Chart on Europe – Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on Europe – Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on Asia – Market size and forecast 2023-2028 ($ million)
Exhibits80: Data Table on Asia – Market size and forecast 2023-2028 ($ million)
Exhibits81: Chart on Asia – Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on Asia – Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on Rest of World (ROW) – Market size and forecast 2023-2028 ($ million)
Exhibits84: Data Table on Rest of World (ROW) – Market size and forecast 2023-2028 ($ million)
Exhibits85: Chart on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on US – Market size and forecast 2023-2028 ($ million)
Exhibits88: Data Table on US – Market size and forecast 2023-2028 ($ million)
Exhibits89: Chart on US – Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on US – Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on China – Market size and forecast 2023-2028 ($ million)
Exhibits92: Data Table on China – Market size and forecast 2023-2028 ($ million)
Exhibits93: Chart on China – Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on China – Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on Germany – Market size and forecast 2023-2028 ($ million)
Exhibits96: Data Table on Germany – Market size and forecast 2023-2028 ($ million)
Exhibits97: Chart on Germany – Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on Germany – Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on UK – Market size and forecast 2023-2028 ($ million)
Exhibits100: Data Table on UK – Market size and forecast 2023-2028 ($ million)
Exhibits101: Chart on UK – Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on UK – Year-over-year growth 2023-2028 (%)
Exhibits103: Chart on Japan – Market size and forecast 2023-2028 ($ million)
Exhibits104: Data Table on Japan – Market size and forecast 2023-2028 ($ million)
Exhibits105: Chart on Japan – Year-over-year growth 2023-2028 (%)
Exhibits106: Data Table on Japan – Year-over-year growth 2023-2028 (%)
Exhibits107: Market opportunity by geography ($ million)
Exhibits108: Data Tables on Market opportunity by geography ($ million)
Exhibits109: Impact of drivers and challenges in 2023 and 2028
Exhibits110: Overview on Criticality of inputs and Factors of differentiation
Exhibits111: Overview on factors of disruption
Exhibits112: Impact of key risks on business
Exhibits113: Vendors covered
Exhibits114: Matrix on vendor position and classification
Exhibits115: Abbott Laboratories – Overview
Exhibits116: Abbott Laboratories – Business segments
Exhibits117: Abbott Laboratories – Key news
Exhibits118: Abbott Laboratories – Key offerings
Exhibits119: Abbott Laboratories – Segment focus
Exhibits120: AbbVie Inc. – Overview
Exhibits121: AbbVie Inc. – Product / Service
Exhibits122: AbbVie Inc. – Key news
Exhibits123: AbbVie Inc. – Key offerings
Exhibits124: ANI Pharmaceuticals Inc. – Overview
Exhibits125: ANI Pharmaceuticals Inc. – Product / Service
Exhibits126: ANI Pharmaceuticals Inc. – Key offerings
Exhibits127: Bausch Health Companies Inc. – Overview
Exhibits128: Bausch Health Companies Inc. – Business segments
Exhibits129: Bausch Health Companies Inc. – Key news
Exhibits130: Bausch Health Companies Inc. – Key offerings
Exhibits131: Bausch Health Companies Inc. – Segment focus
Exhibits132: Cadila Pharmaceuticals Ltd. – Overview
Exhibits133: Cadila Pharmaceuticals Ltd. – Product / Service
Exhibits134: Cadila Pharmaceuticals Ltd. – Key offerings
Exhibits135: Eisai Co. Ltd. – Overview
Exhibits136: Eisai Co. Ltd. – Business segments
Exhibits137: Eisai Co. Ltd. – Key offerings
Exhibits138: Eisai Co. Ltd. – Segment focus
Exhibits139: Evoke Pharma Inc. – Overview
Exhibits140: Evoke Pharma Inc. – Product / Service
Exhibits141: Evoke Pharma Inc. – Key offerings
Exhibits142: GlaxoSmithKline Plc – Overview
Exhibits143: GlaxoSmithKline Plc – Business segments
Exhibits144: GlaxoSmithKline Plc – Key news
Exhibits145: GlaxoSmithKline Plc – Key offerings
Exhibits146: GlaxoSmithKline Plc – Segment focus
Exhibits147: Ipca Laboratories Ltd. – Overview
Exhibits148: Ipca Laboratories Ltd. – Product / Service
Exhibits149: Ipca Laboratories Ltd. – Key offerings
Exhibits150: Medtronic Plc – Overview
Exhibits151: Medtronic Plc – Business segments
Exhibits152: Medtronic Plc – Key news
Exhibits153: Medtronic Plc – Key offerings
Exhibits154: Medtronic Plc – Segment focus
Exhibits155: Otsuka Pharmaceutical Co. Ltd. – Overview
Exhibits156: Otsuka Pharmaceutical Co. Ltd. – Product / Service
Exhibits157: Otsuka Pharmaceutical Co. Ltd. – Key offerings
Exhibits158: Pfizer Inc. – Overview
Exhibits159: Pfizer Inc. – Product / Service
Exhibits160: Pfizer Inc. – Key news
Exhibits161: Pfizer Inc. – Key offerings
Exhibits162: Processa Pharmaceuticals Inc. – Overview
Exhibits163: Processa Pharmaceuticals Inc. – Product / Service
Exhibits164: Processa Pharmaceuticals Inc. – Key offerings
Exhibits165: Takeda Pharmaceutical Co. Ltd. – Overview
Exhibits166: Takeda Pharmaceutical Co. Ltd. – Product / Service
Exhibits167: Takeda Pharmaceutical Co. Ltd. – Key news
Exhibits168: Takeda Pharmaceutical Co. Ltd. – Key offerings
Exhibits169: Vanda Pharmaceuticals Inc. – Overview
Exhibits170: Vanda Pharmaceuticals Inc. – Product / Service
Exhibits171: Vanda Pharmaceuticals Inc. – Key offerings
Exhibits172: Inclusions checklist
Exhibits173: Exclusions checklist
Exhibits174: Currency conversion rates for US$
Exhibits175: Research methodology
Exhibits176: Validation techniques employed for market sizing
Exhibits177: Information sources
Exhibits178: List of abbreviations